Next Article in Journal
Comprehensive Amelioration of Metabolic Dysfunction through Administration of Lactiplantibacillus plantarum APsulloc 331261 (GTB1™) in High-Fat-Diet-Fed Mice
Previous Article in Journal
Scenario Analysis of Food Phosphorus Footprint in Kisumu, a Lakeside East African City in Lake Victoria (Kenya)
Previous Article in Special Issue
Enhancing Encapsulation Efficiency of Chavir Essential Oil via Enzymatic Hydrolysis and Ultrasonication of Whey Protein Concentrate–Maltodextrin
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Foods
Volume 13
Issue 14
10.3390/foods13142226
foods-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Recent Advances of Natural Pentacyclic Triterpenoids as Bioactive Delivery System for Synergetic Biological Applications

by
Wendi Teng
2,
Zixiao Zhou
2,
Jinxuan Cao
2 and
Qing Guo
1,*
1
State Key Laboratory of Food Nutrition and Safety, School of Food Science and Technology, Tianjin University of Science and Technology, Tianjin 300457, China
2
Key Laboratory of Geriatric Nutrition and Health, School of Food and Health, Beijing Technology and Business University, Beijing 100048, China
*
Author to whom correspondence should be addressed.
Foods 2024, 13(14), 2226; https://doi.org/10.3390/foods13142226
Submission received: 17 June 2024 / Revised: 11 July 2024 / Accepted: 13 July 2024 / Published: 16 July 2024
(This article belongs to the Special Issue Preparation, Characterization and Application of the Delivery System for Food Products)
Browse Figures
Versions Notes

Abstract

:
Bioactive compounds have drawn much attention according to their various health benefits. However, poor dissolvability, low stability and limited bioavailability largely narrow their applications. Although a variety of nontoxic ingredients have been rapidly developed as vehicles to deliver bioactive compounds in the last few years, most of them are non-bioactive. Pentacyclic triterpenoids, owing to their unique self-assembly and co-assembly behaviors and different physiological functions, can construct bioactive carriers due to their higher biodegradability, biocompatibility and lower toxicity. In this paper, the basic classification, biological activities and physicochemical properties of pentacyclic triterpenoids were summarized. Additionally, applications of self-assembled and co-assembled pentacyclic triterpenoids as bioactive delivery systems to load bioactive components and future research directions were discussed. This study emphasizes the potential of pentacyclic triterpenoids as bioactive delivery systems, offering a new perspective for constructing self- or co-assemblies for further synergetic biological applications.

1. Introduction

Natural active components attract much attention due to their bioactivities in enhancing the nutritional values and preventing the risks of various diseases like cancers, obesity and diabetes [1,2]. However, bioactive compounds often cannot be completely absorbed by human body [3]. Most of them are not dissolved in water and are very sensitive to environmental stimuli like heat and oxygen, resulting in the decline of stability and limited bioavailability [4]. Moreover, after the bioactive components passed through the gastrointestinal tract, various enzymes and gastric acids would largely decrease the bioactivity [5]. For example, poor solubility of hydrophobic compounds such as resveratrol greatly prevent their dissolution in water and absorption under gastrointestinal conditions in the human body [6,7]. Liposoluble vitamins are often not stable at the stage of processing and storage, or under gastrointestinal conditions [8]. Meanwhile, limited diffusion of the components crossing the intestinal mucus and low permeability through intestinal epithelium largely impeded their bioavailability [9].
In order to overcome these shortcomings, some food matrices were used to embed bioactive compounds to increase their stability and bioavailability [10,11]. Many scientists are focusing on developing delivery platforms including emulsions, nanoparticles (NPs), liposomes and hydrogels, which increase their water solubility, protect from hostile external conditions, and improve intestinal cell permeability [12,13,14]. Nevertheless, these delivery platforms are principally macromolecules or amphiphilic compounds, showing insufficient bioactivities along with easy aggregation, low encapsulation efficiency (EE), loading capacity (LC) and potential safety concerns [15,16,17]. Thus, it is essential to develop new delivery carriers, especially with good bioactivities or biological activities. Recently, some natural small molecules (NSMs) have shown their potential to function as vehicles for their self-assembled supramolecular nanostructures [18,19,20]. The NSMs with bioactivities exhibited superb effects for bioactive delivery and remarkable synergistic bioactivities [21,22]. Among those NSMs, pentacyclic triterpenoids, as a kind of phytochemical, are secondary plant metabolites with chemical structures consisting of five-membered carbon rings [23]. Pentacyclic triterpenoids attracted great attention owing to their remarkable bioactivities but without toxicity [24]. Additionally, avoiding complicated chemical modification, they could form nanostructures via self-assembly or co-assembly, which would greatly enhance their water solubility, bioactivity and oral bioavailability, with no extra components involved [20]. Further, the self/co-assembled nanostructures have great potential as carriers to embed hydrophobic foods and drugs [4]. Pentacyclic triterpenoids showed synergistic biological activities compared with conventional drug delivery systems. Besides the advantages of higher water solubility, improved stability and controlled release, pentacyclic triterpenoids are capable of targeted delivery, offering promising roles for them except for purely biologically active components.
Many reviews have been published on the bioactivities or physicochemical properties of pentacyclic triterpenoids [25,26,27]. However, there are no comprehensive reports on the applications of pentacyclic triterpenoids as nanocarriers for the encapsulation of bioactive components. In this review, the basic classification, biological activities and physicochemical properties of pentacyclic triterpenoids were first summarized. Additionally, applications of self-assembled and co-assembled pentacyclic triterpenoids as delivery systems to load bioactive components were compared and discussed. Last, challenges and future research directions of pentacyclic triterpenoids as delivery systems were proposed and analyzed. This work offers comprehensive knowledge of pentacyclic triterpenoids and highlights their potential as bioactive nanocarriers, offering a novel perspective for constructing pentacyclic triterpenoids-based self/co-assemblies for synergetic effects.

2. Distribution of Pentacyclic Triterpenoids in Nature

Triterpenes are composed of six isoprene units with 30 carbon atoms, are secondary metabolites in nature [23]. Pentacyclic triterpenoids consist of 6-6-6-6-5 or 6-6-6-6-6 as skeletal units, which are one kind of active triterpenes commonly found in plants, monocotyledons, dicotyledons, fungi, marine organisms and pteridophytes [25]. They often exist in Leguminosae, Araliaceae, Cucurbitaceae, Compositae, Poaceae and other plants [28]. According to the skeletal structures, the main types of pentacyclic triterpenes were summarized in Figure 1, including oleanane-type, ursane-type, lupane-type and friedelane-type [29].
Oleanane-type are also called β-amyrin-derived pentacyclic triterpenoids. They are always presented in the form of free or combined saponins [30]. Oleanolic acid, glycyrrhetinic acid, arjunolic acid, maslinic acid, esculentoside and polygalacic acid belong to oleanane-type pentacyclic triterpenoids [31]. Ursane-type are as well known as α-amyrin-derived pentacyclic triterpenoids, which have 6-6-6-6-6 as skeletal units. They are often presented in the free form or glycosides from Ilex chinensis, Sanguisorba officinalis and others. Ursolic acid, corosolic acid and asiatic acid are the typical representatives [32]. There are 6-6-6-6-5 as skeletal units for the lupane-type pentacyclic triterpenoids. Among them, betulinic acid, betulonic acid, betulinol and lupeol are widely studied [33]. Friedelane originates from oleanane via methyl translocation. Friedelin and friedelanol, extracted from tripterygium wilfordii, belong to friedelane-type pentacyclic triterpenoids [34]. Furthermore, tingenone exists in Euonymus, and pristimerin is presented in Celastrus [35].
Furthermore, a few other types of pentacyclic triterpenoids, like fernane and hopane, could also be found in nature [25]. Fernane and isofernane are the isomers of lupane. Fernenol, mainly extracted from Citrullus colocynthis leaves, is the typical representative of fernane-type pentacyclic triterpenoids [36]. Cylindrin, originating from Imperata cylindrica, is the typical representative of the isofernane type [37]. Hopane is the isomer of fernane. Hopane-type pentacyclic triterpenoids could be extracted from Aquilaria sinensis [38]. 2-hydroxydiplopterol was isolated from the metabolites produced by the halotolerant fungal strain Aspergillus variecolor B-17 [39].

3. Biological Activities of Pentacyclic Triterpenoids

Regularly intaking plant-based foods, such as pawpaw, Chinese ziziphus jujuba and strawberries could lower the incidence of various diseases [40]. The diverse structures of pentacyclic triterpenes determine their varied bioactivities. Pentacyclic triterpenes, with a perceptible improvement in the pharmacological activity, have been shown to have significant therapeutic and tissue-protective effects, including anti-tumor, hepatoprotective, glucose-regulating effects, among others (Figure 2), which are important for the improvement of body functions [25].

3.1. Anti-Tumor Activity

In recent research, pentacyclic triterpenoids derived from plants have shown great potential antitumor activity [41]. They could function as molecular targets and cell proliferation regulatory, including inhibiting DNA polymerase, regulating apoptosis, modulating autophagy-related protein, altering the cell cycle in its early phases, changing signal transduction, interfering with angiogenesis and differentiation, inhibiting proliferation and metastasis [42]. Oleanolic acid showed potential antitumor activity in breast cancer, lung cancer and liver cancer, as well as no side effects [43]. The involved pathways included activation of AMP-activated protein kinase pathway, inhibition of PI3K Akt/mTOR/NF-κB signaling pathway, upregulation of p53 mediated activation of mitochondrial apoptotic pathway, and blocking the release of anti-apoptotic inhibitor of apoptotic protein (IAP) family proteins [44]. Ursolic acid exerted anticancer efficacy by inhibiting proliferation, increasing apoptosis, modulating growth receptors, decreasing cellular oxygen consumption, and enhancing NO levels [45]. Betulinic acid demonstrated a selective antitumor activity on human melanoma cell lines both in vitro and in vivo, but minimal toxicity against normal cells was observed [46]. Pentacyclic triterpenoids, naturally isolated active ingredients, could be used as a safer alternative in preventing cancers due to their cytotoxicity to cancer cells but less toxicity to normal cells.

3.2. Hepatoprotective Activity

The hepatoprotective activity of pentacyclic triterpenoids has a long history and mature application in China, from the hepatic protection of licorice in the traditional Chinese “Shen Nong Ben Cao Jing” to modern application of over-the-counter hepatoprotective drugs [47,48]. Glycyrrhetinic acid, as one of the most important functional components in licorice, was proven to have a hepatoprotective effect. Glycyrrhetinic acid demonstrated anti-inflammatory effects on propionibacterium acne-induced liver injury by inhibiting macrophage inflammatory protein (MIP)-1 in Kupffer cells by downregulating MyD88 and NF-κB. Glycyrrhetinic acid also regulated the proliferation of liver-infiltrating CD4+T cells and suppressed proinflammatory cytokines [49]. Oleanolic acid was used as a hepatic drug for more than 20 years due to hepatoprotective effects. Researchers concluded oleanolic acid could increase the activity of alanine, reduce liver inflammation, promote the regeneration of liver cells and enable rapid recovery of necrotic liver tissue. It not only prevented liver fibrosis and cirrhosis, but also resisted liver damage caused by various chemicals or active substances [50]. Ursolic acid was shown to protect tetrachloride-induced oxidative damage and greatly increase the survival rate of hepatocytes when compared to tetrachloride-exposed cells, suggesting ursolic acid had strong hepatic protective activity by maintaining the glutathione as well as restraining the malondialdehyde formation according to its radical scavenging functionalities [51]. Additionally, ursolic acid has been shown to protect against ethanol-mediated chronic liver injury through an antioxidant pathway [52].

3.3. Glucose-Regulating Activity

The antidiabetic activities of pentacyclic triterpenoids have been explored both in vivo and in vitro. Pentacyclic triterpenoids decreased plasma glucose, HbA1c, enhanced plasma insulin, muscle and liver glycogen, and showed protective effects on the liver, eye and heart of diabetic rats, suggesting that they had the potential to prevent diabetes and associated complications [53]. Oleanolic acid alleviates diabetes and metabolic syndrome by improving insulin sensitivity [54]. In rodent studies, oleanolic acid also attenuated fructose-induced hyperglycemia by regulating enzymes involved in carbohydrate digestion, insulin secretion and insulin signaling [55]. Ursolic acid was reported to inhibit pancreatic α-amylase activity and decrease the blood glucose level both in vivo and in vitro [56,57]. 2.5–10 µM of ursolic acid raised the expression of the transcription factors PPARγ, sterol regulatory factor binding protein 1c (SREBP-1c), fatty acid-synthase and fatty acid binding protein 4 (FABP4) [58]. Betulinic acid could enhance insulin sensitivity, and alleviate the blood glucose, inflammation, dyslipidemia and oxidative stress in high-fructose diet-induced metabolic syndrome by activating PI3K/Akt signal pathways [59]. Betulinic acid was also effective at ameliorating TNF-α-induced insulin resistance by preventing the negative regulator of insulin signaling and inflammation-activated protein kinase in adipocytes, thus potentially relieving insulin resistance [29,60].

3.4. Others

Pentacyclic triterpenoids have been reported in some other biological activities in the last few years. They were mainly used to inhibit viral replication and reduce reverse transcriptase activity and protease activity as a way to defend against self-replication of HIV [61]. Among 191 pentacyclic triterpenoids reported, 85 have shown high anti-parasitic activity against various species belonging to the genera of plasmodium, leishmania, trypanosoma, as well as various genera of nematoda [62]. Oleanolic acid protects against myocardial ischemia-reperfusion injury by enhancing glutathione and α-tocopherol-mediated mitochondrial antioxidation and ameliorates high glucose-induced endothelial dysfunction by activating PPARδ [63]. Ursolic acid has antimicrobial properties against several harmful pathogens including bacteria, viruses, fungi and parasites [64]. Ursolic acid could kill bacteria and inhibit bacterial growth by altering bacterial cell membranes and adhesion proteins [65]. In addition, cell morphology and expression levels of virulence factors, such as pili and fritillary were regulated by ursolic acid [66]. These highly biological activities with low toxicity made it possible for them to be used as alternatives to traditional chemotherapeutics.

4. Self-Assembly and Co-Assembly Properties of Pentacyclic Triterpenoids

Intermolecular noncovalent interactions, including electrostatic interactions, hydrogen bonding, hydrophobic interactions, π-π stacking interactions and van der Waals interactions could drive molecular assembly [67]. Spontaneous self-assembly forming supramolecular architectures have vital potentials in the fields of delivery vehicles, generation of hybrid materials, nanobiodiagnostics, and so on [68]. In the past few years, the self-assembly of natural compounds such as sugars, amino acids and fatty acids has been reported [69]. In 2011, Bag first found that several natural triterpenoids were of nano-meter dimensions with various rigid or flexible lengths, which could self-assemble in different solutions yielding nanoarchitectures like vesicles, fibers, flowers or spheres [70]. Among triterpenoids, pentacyclic triterpenoids are of great significance, which diversified structures lead to self-assembly properties: (1) Their fused 6-6-6-6-6 or 6-6-6-6-5 skeletal units provide a nano-sized rigid backbone; (2) The hydroxyl and carboxyl groups, with the amphiphilic nature and hydrogen bond, provide promising self-assembly properties; (3) The in-built centers of chirality make them useful as chiral building blocks. These different numbers and types of carboxyl, hydroxyl or other groups at different positions and spatial orientations have great influences on the self-assembly properties, leading to various sizes and morphologies [71]. Betulinic acid could self-assemble in 19 organic liquids and alcohol-water mixtures forming gels with a fibrillar network [72]. Betulin and lupeol enabled them to self-assemble in many liquids with various morphologies and similar rheological properties [73]. Likewise, both self-assembled glycyrrhetinic acid and oleanolic acid generated spheres, vesicles or fibrils to form supramolecular gels [74]. Additionally, ursolic acid was shown to stably self-assemble to supramolecular gel enhancing solubility and anticancer effects [75,76].
Co-assembly is an effective and convenient strategy to construct “multi-bioactive” delivery vehicles. Supramolecular co-assembly has been widely used to construct carrier platforms because of their practicality and simplicity [77]. With the increased self-assembled pentacyclic triterpenoids, constructing co-assembled vehicles along with multi-bioactivities has become possible. During the process of co-assembly, NPs could not only maintain the biological activity of each compound but also modulate the self-assembled morphologies and sizes to achieve combination therapy [22].

5. Applications of Pentacyclic Triterpenoids as Bioactive Delivery System

5.1. Directed Self-Assemblies

Pentacyclic triterpenoids are often widely distributed and could be derived from diversified plants. Their various biological activities help treat or prevent many diseases. However, low physicochemical stability and poor bioavailability limit the applications of bioactive compounds in various fields. For example, the bioavailabilities of curcumin, β-carotene and α-tocopherol were proved to be lower than 5%, which resulted in a waste of cost and time spent to produce them and showed inefficient health-promoting results [78]. In recent decades, encapsulating bioactive compounds to protect from multiple food processing and increase delivery efficiency has attracted great interest from food scientists, but nano-vehicles might go along with high toxicity as well as possible immunogenicity, therefore enhancing product costs and bringing unanticipated risks. Though various nontoxic ingredients have rapidly developed as vehicles to deliver bioactive compounds in the last few years, they are all non-bioactive [79]. Pentacyclic triterpenoids, owing to their unique self-assembly/co-assembly behaviors and different physiological functions, can construct carriers for further synergetic biological applications, which have brought great potential in many fields due to their more biodegradability, biocompatibility and lower toxicity. Until now, only a few pentacyclic triterpenoids have been developed for bioactive delivery, since not all pentacyclic triterpenoids can self-assemble to vehicles with a proper morphology and size, or good biological functions. All self-assembled pentacyclic terpenoids have been explored and compared in how to release active compounds and function as bioactive delivery carriers, and the specific information is listed in Table 1.

5.1.1. Oleanolic Acid

Limited water dispersibility and stability of β-carotene (Car) largely prevent its functions and uses in the field of the food industry. Self-assembled oleanolic acid was used as a delivery system to load hydrophobicCar. After the optimization, LC and EE reached 32.6% and 80.7%, respectively. Self-assembled oleanolic acid NPs could embed up to 300 mg/g of Car. Hydrogen bonding and hydrophobic interactions between oleanolic acid and Car were the main forces promoting self-assembly and capsulation. Compared to free Car, Car/oleanolic acid NPs greatly increased aqueous solubility and protected against UV radiation, ionic strength, and heat. Moreover, Car/oleanolic acid NPs offered delayed release in simulated gastric conditions and controlled release in intestinal conditions. In addition, Car/oleanolic acid NPs showed better hepatoprotective and antioxidant effects [80].
Paclitaxel (PTX) is an anti-cancer chemotherapeutic agent but with certain toxic side effects on normal cells. Self-assembled oleanolic acid was constructed to encapsulate PTX, with 17.1% of the maximal LC and 62.6% of maximal EE [81]. An amount of 280 mg/g of PTX could be encapsulated by oleanolic acid supramolecular NPs. Molecular simulation showed that the assembly process is mainly through hydrophobic interaction and hydrogen bonding interaction. Oleanolic acid could form an assembled nanostructure with the carboxyl group facing the continuous phase and the hydroxyl group dispersed phase. Along with the organic phase volatilized, oleanolic acid molecules gradually aggregate, forming a compactly packed bilayer shell structure through the hydrophobic interaction. Oleanolic acid went on to internally extend loosely to form the intermediate layer of oleanolic acid NPs. When adding the PTX, intermediate layers and the internal hydrophobic area were filled by aggregates via PTX-OA interaction, forming core-shell structures. PTX/oleanolic acid NPs showed slow and sustained release of PTX and were more stable under acidic conditions. In-vitro and in-vivo research demonstrated that PTX/ oleanolic acid NPs had synergistic antitumor effects due to different mechanisms, with an approximately 18% higher rate of tumor inhibition than the PTX group. Liver injury was largely decreased owing to the hepatoprotective activity of oleanolic acid. These studies showed that oleanolic acid could be used as bioactive nanocarriers to deliver hydrophobic nutrients, bioactive components and chemotherapeutic agents, so as to show synergetic effects and lowered side effects.

5.1.2. Ursolic Acid

Self-assembled ursolic acid NPs were developed as a new “self-contained bioactive nanocarrier” to load PTX by hydrogen bonding and hydrophobic interaction. The resulting PTX/ursolic acid NPs showed a uniformly dispersed nanosphere structure with 23.12 ± 1.07% of LC and 94.41 ± 4.28% of EE after optimization. The highest loading capacity of ursolic acid supramolecular NPs for PTX was up to 230 mg/g. They had excellent stability in PBS for at least 15 days, and in serum for 24 h. Likewise, they dissociated gradually and released active components after entering the cells. PTX/ursolic acid NPs significantly prolonged the plasma half-life and showed highly efficient synergistic antitumor efficacy. The inhibition rate in mice was up to 90%, 3.3 times higher than that in the PTX group. Further, PTX/ursolic acid NPs significantly alleviated liver injury, showing that ursolic acid, as a “self-contained bioactive nanocarrier”, was biosafe and enabled reduced liver damage induced by chemotherapeutics via key antioxidant pathways [82].
At the same time, Braja Gopal Bag et al. demonstrated that the vesicular self-assembled ursolic acid gel was capable of entrapping cationic dye Rhodamine B (Rho-B), anionic dye 5,6-carboxfluorescein (CF) and chemotherapeutic agent doxorubicin (DOX) by comparative fluorescence intensity, respectively. Hydrogen bonding involving hydroxyl and carboxyl groups and the dispersion interactions by the triterpenoid backbones might play an important part in the self-assembly. An amount of 87% of Rho B was controllably released after 23 h 30 min at physiological conditions and 75% of DOX was released after 30 min at physiological conditions. Surprisingly, 88% of DOX was released after 60 min at pH 6.6, imitating the low pH environment of hypoxic tumors or endosomes [77]. All these works make ursolic acid possible as a prospective delivery vehicle for scientific and industrial fields.

5.1.3. Betulinic Acid

Glyburide is a promising tested agent for stroke by mediating cerebral edema, but has a limited ability to pass the blood-brain barrier [23]. Betulinic acid NPs were employed as a bioactive multifunctional vehicle to markedly increase the delivery of glyburide to the brain, leading to synergetic effects for ischemic stroke by nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase (HO-1) antioxidant pathway, compared with either glyburide or betulinic acid NPs. 91% of glyburide was controllably released and retained in the brain over three days [23]. Currently, in clinical practice, a low dose (3 mg/d) of glyburide has been used, thus limiting its efficacy. However, a higher dose of glyburide would lead to hypoglycemia. Betulinic acid NPs decrease glyburide to be exposed to the circulatory system, lowering the risk of hypoglycemia. It not only enhanced the delivery of glyburide to brain tissue, but also decreased the side effects. Furthermore, glyburide-encapsulated betulinic acid NPs showed the simplest and high-efficiency way to intervene in both cerebral edema and oxidation, two critical targets for stroke treatment [51]. Additionally, glyburide/betulinic acid NPs improved patient convenience. Owing to the low brain retention and short blood half-life, continuous infusion for 72 h by osmatic pumps was needed for glyburide administration in vivo [12]. Glyburide/betulinic acid NPs would be sufficient to bring remarkable therapeutic benefits.

5.1.4. Betulonic Acid

Supramolecular self-assembled betulonic acid NPs were formed to load PTX mainly by hydrogen bond and hydrophobic interaction. The contact angle of PTX-loaded betulonic acid NPs was 77.5°, showing improved water dispersibility, and it helped keep stability under acidic conditions. In-vitro and in-vivo data found that PTX/betulonic acid NPs enabled precisive targeting, increased PTX bioavailability by increasing the permeability and retention effect, and showed superb synergistic anti-tumor efficacy by different anti-tumor mechanisms of betulonic acid and PTX. These self-assembled NPs showed various advantages of nanovehicles, like excellent water dispersibility, proper morphologies and sizes, prolonged plasma half-life and enhanced cell uptake and targeting. In addition, it increased biosafety and reduced the toxicity to normal tissues and cells [83].
In photodynamic therapy, chlorin e6 (Ce6) is often used as a photosensitizer because of its efficient antitumor effect. Assembly strategies were used to construct betulonic acid-mediated photosensitizers with no structural modifications. Intermolecular π-π stacking and hydrophobic interactions might be the primary driving forces. Ce6/betulonic acid NPs kept stable in water, cell cultural medium and PBS buffer, and also had better photostability and anti-photobleaching ability than free Ce6. The assembled Ce6/betulonic acid NPs prolonged blood circulation and exhibited a significantly increased, synergistic anticancer efficacy by promoting ROS generation [84].

5.1.5. Arjunolic Acid, Corosolic Acid and Maslinic Acid

Gel could often be utilized as smart scaffolds for extensive delivery, whose fibrillary structures enabled stable release and protected from premature degradation, extending the circulation time and lowering the cytotoxicity. Additionally, the fibrillary networks facilitated to be taken up easily by cells, thus increasing the therapeutic effects. Arjunolic acid, corosolic acid and maslinic acid can also respectively self-assemble to vesicular gels to entrap Rho B, CF or DOX in aqueous solvent mixtures respectively and controlled release of the entrapped molecules at physiological pH or mediated by surfactant, indicating their usefulness as delivery vehicles [85,86,87]. Researchers need to further explore their potential for use in health benefits.

5.2. Multi-Components Co-Assemblies

Different from multi-component-directed self-assemblies, supramolecular co-assemblies were novel chemical entities based upon various non-covalent interactions to combine with different components, which could function as co-delivery systems. All co-assembled pentacyclic terpenoids have been explored and the related information is listed in Table 2.

5.2.1. Oleanolic Acid-Glycyrrhetinic Acid/PTX

A pure natural co-assembled delivery system was formed through directly co-assembling oleanolic acid and glycyrrhetinic acid through hydrogen bonding and hydrophobic interactions. PTX could be entrapped in the co-assembled vehicles with 15.1 ± 0.4% of maximum LC and 98.8 ± 1.0% of EE. The maximal loading of glycyrrhetinic acid-oleanolic acid co-assembled NPs for PTX was up to 150 mg/g. PTX-loaded oleanolic acid+ glycyrrhetinic acid NPs were relatively stable under acidic conditions, and also had good dispersion and chemical stability at room temperature over 2 months as well as in serum for at least 48 h. 84 ± 9.9% of PTX could gradually dissociate and continuously released after being engulfed by the cells. In-vitro and in-vivo studies have demonstrated synergistic anticancer activities and the tumor inhibition rate increased from 58.9% to 82.6%. In addition, compared with free PTX, they could alleviate liver damage by regulating key antioxidant pathways and reduce the risk of nanotoxicity, due to the unique anti-inflammatory and hepatoprotective effects of oleanolic acid and glycyrrhetinic acid [22].

5.2.2. Carrier-Free Nanodelivery System

A “core-shell” co-assembly carrier-free system was constructed based on ursolic acid self-assembled as core and epigallocatechin gallate (EGCG) self-polymerized to form a uniform layer as a shell with aptamer modification. The carrier-free system was pH-responsive and kept stable in a normal extracellular environment, but released rapidly in weak acid condition where tumor existed. It increased tumor cellular uptake and long circulation. Ursolic acid combined with EGCG activated the innate immunity resulting in a significant synergistic anti-hepatocellular carcinoma effect. Moreover, the carrier-free system showed low cytotoxicity in normal cells, good biosafety of organic tissues and enlarged tumor accumulation in vivo [90]. Glycyrrhetinic acid/oleanolic acid and Glycyrrhetinic acid/liquidambaric acid NPs were combined via a supramolecular assembly mechanism of non-covalent interactions to form a carrier-free system, which not only enhanced cellular uptake and passive targeting tumor ability, but also arrested cell cycle at different stages of cancer cells and induced apoptosis, demonstrating synergistic anticancer effects with reliable biosafety when comparing to every single component [89]. However, not all the co-assemblies would be effective. For example, co-assembled morphologies were not observed in ursolic acid/betulinic acid, glycyrrhetinic acid/lupeol and ursolic acid/liquidambaric acid [89]. It might be due to hydrophobic forces not driving to form supramolecular nanostructures based on their spatial orientation of carboxyl, hydroxyl or other groups.

6. Conclusions and Further Perspectives

Pentacyclic triterpenoids are pivotal natural active components with various biological activities, but poor water dispersibility, poor absorption and rapid metabolism, which is largely influenced their applications. Nowadays, a variety of vehicles have been developed to deliver pentacyclic triterpenoids [91]. Despite these merits, the drawback of these delivery systems is their low loading capacity. For example, the loading capacity of asiatic acid in glyceryltristearate solid lipid nanoparticles is just 2.1% to 5.0% [92]. Merely 3.35% to 12.05% ursolic acid was embedded by a nanostructured lipid carrier coated with chitosan oligosaccharides [93] (Das et al., 2017). Furthermore, large amounts of inactive vehicle materials not only expanded the cost but also brought safety concerns [94].
According to the current research, pentacyclic triterpenoids could be a good matrix that acts as biocompatible nanocarriers. Their spontaneous, reversible self-assembly results from the generation of intermolecular forces, mainly by hydrogen bonds of carboxyl and hydroxyl groups, as well as the dispersing forces of the non-polar triterpenoid skeleton. Discovering the self-assembly properties was recorded as a breakthrough in natural products. Unique nanostructures with various physical characteristics enabled them to form NPs in different sizes and shapes. Surprisingly, the loading capacity of self-assembled/co-assembled pentacyclic triterpenoids was quite higher than that of other delivery systems. Meanwhile, the spontaneous assembly of pentacyclic triterpenoids offered biological activities, which eliminated cytotoxicity and complicated synthesis; it not only provided effective strategies to develop novel therapies, but also helped establish new usage of old drugs.
Although the self-assembled NSMs have attracted much attention, various theoretical and technological problems still need to be overcome. We have proposed several research perspectives in both basic research and applications (Figure 3): (1) Though assembled pentacyclic triterpenoids were used for drug encapsulation, there have been few studies on entrapping food nutritional components for food applications. Nano-delivery systems based upon pentacyclic triterpenoids can be used in the food industry to develop products such as special medical foods, healthy nano-foods and nano-nutrient supplements to meet special needs for people with limited access to food, digestive and absorption disorders or specific disease states for nutrients or diets. They can also be used to prevent the occurrence of certain health problems and improve health status. It provides a novel strategy for nutraceuticals to improve instability, low bioavailability and synergistic effects with no toxicity. Thus, more in-vivo research is needed to explore the gastrointestinal fate of different pentacyclic triterpenoids as bioactive delivery systems so that their safety and efficacy can be established. The bioavailability assessment of bioactive pentacyclic triterpenoids in various food products still needs to be conducted. In addition, a strict regulatory system managing their applications in the food field would be addressed. (2) There is an increasing focus on exploring precise treatments for the public. Designing “smart” nanoformulations, that can release bioactive compounds from the vehicles with stimulus, is one of the future directions [95]. For example, the chitosan at the surface of nanovehicles facilitated the rapid release of the bioactive compounds to a low-pH environment, a microenvironmental characteristic of the tumors, thus enhancing the therapy efficiency [96]. Pentacyclic triterpenoids-derived NPs endow tissues with targeting ability, allowing for targeted delivery with no additional chemical modifications. The cancer-targeting was reported to be achieved by combining folate, lactoferrin or lactobionic acid residues with the nanocarriers, increasing the cellular uptake [97,98]. Deng et al. reported that betulinic acid could interact with the CB1 receptor, which facilitated efficient brain penetration [23]. Reversible non-covalent interactions could highly respond to stimuli such as pH, light and heat. In addition, the targeting of nanovehicles to the proper tissues or organs could decrease the side effects of treatment. Thus, pentacyclic triterpenoids can be designed as vehicle platforms with stimuli-responsiveness or active targeting to enlarge the anticancer, antimicrobial, antiviral and other biological activities. (3) A large amount of research has reported that self-assembled/co-assembled pentacyclic triterpenoids could enhance their efficiency in antitumor treatment. Surprisingly, cytotoxicity was not observed when incubated with normal cell lines, showing superior selectivity for cancer therapy. Future scientists could not only concentrate on their anticancer effects but also pay more attention to their other biological activities. Owing to the self-assembly and co-assembly properties, it would be possible to develop combined prevention or treatments for metabolic syndrome such as hyperglycemia and hyperlipidemia. A few bioactive pentacyclic triterpenoids could be released in a changing environment, which would also help decrease the dosages, reduce the multi-drug resistance and achieve synergistic therapeutic effects. Further in-vivo and interdisciplinary studies are needed to assess the pros and cons of such bioactive delivery systems over extended periods. All efforts would contribute to the enhancement of natural pentacyclic triterpenoids as a bioactive delivery system for synergetic biological applications, therefore improving the life quality of human beings. (4) Nowadays, self-assembled pentacyclic triterpenoids are almost prepared via conventional or modified emulsion-solvent evaporation method, which limits more pentacyclic triterpenoids with assembled properties and bioactivities to be discovered, considering their wide structural diversities. Larger scales, lack of delivery practicability, low drug loading efficiency and poor aqueous solubility also largely limited their further applications. Thus, developing multiple efficient emerging techniques or modifications to existing methods that could improve scalability, drug loading efficiency, and aqueous solubility, and exploring the physicochemical properties and biological activities of more pentacyclic triterpenoids are urgently needed in the near future, and can significantly help expand the delivery development.

Author Contributions

Conceptualization, W.T. and Q.G.; methodology, writing—original draft preparation, Z.Z.; writing—review and editing, W.T. and J.C.; visualization, W.T. and Q.G.; supervision, J.C. and Q.G.; project administration, W.T. and Q.G.; funding acquisition, W.T. and Q.G. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Open Project Program of the State Key Laboratory of Food Nutrition and Safety (No. SKLFNS-KF-202301) and the Ministry of Science and Technology of China, the fund of Cultivation Project of Double First-Class Disciplines of Food Science and Engineering, Beijing Technology & Business University (No. BTBUYXTD202202).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Conflicts of Interest

The authors declare that there are no conflicts of interest.

References

  1. Oh, Y.S. Bioactive compounds and their neuroprotective effects in diabetic complications. Nutrients 2016, 8, 472. [Google Scholar] [CrossRef] [PubMed]
  2. Datta, S.; Bhattacharya, S. Multifarious facets of sugar-derived molecular gels: Molecular features, mechanisms of self-assembly and emerging applications. Chem. Soc. Rev. 2015, 44, 5596–5637. [Google Scholar] [CrossRef]
  3. Wani, T.A.; Shah, A.G.; Wani, S.M.; Wani, I.A.; Masoodi, F.A.; Nissar, N.; Shagoo, M.A. Suitability of different food grade materials for the encapsulation of some functional foods well reported for their advantages and susceptibility. Crit. Rev. Food Sci. Nutr. 2016, 56, 2431–2454. [Google Scholar] [CrossRef]
  4. Huang, L.; Huang, X.H.; Yang, X.; Hu, J.Q.; Zhu, Y.Z.; Yan, P.Y.; Xie, Y. Novel nano-drug delivery system for natural products and their application. Pharmacol. Res. 2024, 201, 107100. [Google Scholar] [CrossRef] [PubMed]
  5. Zhong, H.; Zhu, Y.; Yu, J.; Xu, X.; Gleeson, J.P.; Ryan, S.M.; Brayden, D.J. Oral delivery strategies for nutraceuticals: Delivery vehicles and absorption enhancers. Trends Food Sci. Technol. 2016, 53, 90–101. [Google Scholar]
  6. Furr, H.C.; Clark, R.M. Intestinal absorption and tissue distribution of carotenoids. J. Nutr. Biochem. 1997, 8, 364–377. [Google Scholar] [CrossRef]
  7. Teng, W.; Zhao, L.; Yang, S.; Zhang, C.; Liu, M.; Luo, J.; Jin, J.; Zhang, M.; Bao, C.; Li, D.; et al. The hepatic-targeted, resveratrol loaded nanoparticles for relief of high fat diet-induced nonalcoholic fatty liver disease. J. Control. Release 2019, 307, 139–149. [Google Scholar] [CrossRef] [PubMed]
  8. Borel, P.; Dangles, O.; Kopec, R.E. Fat-soluble vitamin and phytochemical metabolites: Production, gastrointestinal absorption, and health effects. Prog. Lipid Res. 2023, 90, 101220. [Google Scholar] [CrossRef]
  9. Gonnet, M.; Lethuaut, L.; Boury, F. New trends in encapsulation of liposoluble vitamins. J. Control. Release 2010, 146, 276–290. [Google Scholar] [CrossRef]
  10. Katouzian, I.; Jafari, S.M. Nano-encapsulation as a promising approach for targeted delivery and controlled release of vitamins. Trends Food Sci. Technol. 2016, 53, 34–48. [Google Scholar] [CrossRef]
  11. Guo, Y.; Qiao, D.; Zhao, S.; Zhang, B.; Xie, F. Starch-based materials encapsulating food ingredients: Recent advances in fabrication methods and applications. Carbohyd. Polym. 2021, 270, 118358. [Google Scholar] [CrossRef]
  12. Chen, S.; McClements, D.J.; Jian, L.; Han, Y.; Dai, L.; Mao, L.; Gao, Y. Core–shell biopolymer nanoparticles for co-delivery of curcumin and piperine: Sequential electrostatic deposition of hyaluronic acid and chitosan shells on the zein core. ACS Appl. Mater. 2019, 41, 38103–38115. [Google Scholar] [CrossRef]
  13. Huang, H.; Belwal, T.; Liu, S.; Duan, Z.; Luo, Z. Novel multi-phase nano-emulsion preparation for co-loading hydrophilic arbutin and hydrophobic coumaric acid using hydrocolloids. Food Hydrocoll. 2019, 93, 92–101. [Google Scholar] [CrossRef]
  14. Wei, Z.; Gao, Y. Physicochemical properties of β-carotene bilayer emulsions coated by milk proteins and chitosan-EGCG conjugates. Food Hydrocoll. 2016, 52, 590–599. [Google Scholar] [CrossRef]
  15. Kim, J.Y.; Huber, K.C. Preparation and characterization of corn starch β-carotene composites. Carbohyd. Polym. 2016, 136, 394–401. [Google Scholar] [CrossRef]
  16. Zhu, F. Encapsulation and delivery of food ingredients using starch based systems. Food Chem. 2017, 229, 542–552. [Google Scholar] [CrossRef]
  17. Cui, F.; Han, S.; Wang, J.; McClements, D.J.; Liu, X.; Liu, F. Co-delivery of curcumin and epigallocatechin gallate in W/O/W emulsions stabilized by protein fibril-cellulose complexes. Colloids Surf. B Biointerfaces 2023, 222, 113072. [Google Scholar] [CrossRef]
  18. Fu, S.; Yang, X. Recent advances in natural small molecules as drug delivery systems. J. Mater. Chem. B 2023, 11, 4584–4599. [Google Scholar] [CrossRef] [PubMed]
  19. Cheng, J.; Wang, S.; Zhao, H.; Liu, Y.; Yang, X. Exploring the self-assembly mechanism and effective synergistic antitumor chemophototherapy of a biodegradable and glutathione responsive ursolic acid prodrug mediated photosensitive nanodrug. Biomater. Sci. 2021, 9, 3762–3775. [Google Scholar] [CrossRef]
  20. Lin, B.; Peng, X.; Cheng, J.; Wang, J. Natural gambogic acid-tuned self-assembly of nanodrugs towards synergistic chemophototherapy against breast cancer. J. Mater. Chem. B 2024, 12, 5940–5949. [Google Scholar] [CrossRef]
  21. Yang, X.; Ma, C.; Chen, Z.; Liu, J.; Liu, Y.; Xie, R.; Zhao, H.; Deng, G.; Chen, A.T.; Gong, N.B.; et al. Single small molecule-assembled nanoparticles mediate efficient oral drug delivery. Nano Res. 2019, 12, 2468–2476. [Google Scholar] [CrossRef]
  22. Wang, J.; Zhao, H.; Qiao, W.; Cheng, J.; Han, Y.; Yang, X. Nanomedicine-cum-carrier by co-assembly of natural small products for synergistic enhanced antitumor with tissues protective actions. ACS Appl. Mater. 2020, 12, 42537–42550. [Google Scholar] [CrossRef] [PubMed]
  23. Deng, G.; Ma, C.; Zhao, H.; Zhang, S.; Liu, J.; Liu, F.; Chen, Z.; Chen, A.T.; Yang, X.; Avery, J.; et al. Anti-edema and antioxidant combination therapy for ischemic stroke via glyburide-loaded betulinic acid nanoparticles. Theranostics 2019, 9, 6991–7002. [Google Scholar] [CrossRef] [PubMed]
  24. Ghante, M.H.; Jamkhande, P.G. Role of pentacyclic triterpenoids in chemoprevention and anticancer treatment: An overview on targets and underling mechanisms. J. Pharmacopunct. 2019, 22, 55–67. [Google Scholar] [CrossRef] [PubMed]
  25. Li, Y.; Wang, J.; Li, L.; Song, W.; Li, M.; Hua, X.; Wang, Y.; Yuan, J.; Xue, Z. Natural products of pentacyclic triterpenoids: From discovery to heterologous biosynthesis. Nat. Prod. Rep. 2023, 40, 1303–1353. [Google Scholar] [CrossRef] [PubMed]
  26. Zheng, X.Q.; Song, L.X.; Han, Z.Z.; Yang, Y.B.; Zhang, Y.; Gu, L.H.; Yang, L.; Chou, G.X.; Wang, Z.T. Pentacyclic triterpenoids from spikes of Prunella vulgaris L. with thyroid tumour cell cytostatic bioactivities. Nat. Prod. Res. 2023, 37, 1518–1526. [Google Scholar] [CrossRef] [PubMed]
  27. Zhang, S.; Peng, B.; Chen, Z.; Yu, J.; Deng, G.; Bao, Y.; Ma, C.; Du, F.; Sheu, W.C.; Kimberly, W.T.; et al. Brain-targeting, acid-responsive antioxidant nanoparticles for stroke treatment and drug delivery. Bioact. Mater. 2022, 16, 57–65. [Google Scholar] [CrossRef] [PubMed]
  28. Wang, C.; Wu, P.; Tian, S.; Xue, J.; Xu, L.; Li, H.; Wei, X. Bioactive pentacyclic triterpenoids from the leaves of Cleistocalyx operculatus. J. Nat. Prod. 2016, 79, 2912–2923. [Google Scholar] [CrossRef] [PubMed]
  29. Xu, R.; Fazio, G.C.; Matsuda, S.P.T. On the origins of triterpenoid skeletal diversity. Phytochemistry 2004, 65, 261–291. [Google Scholar] [CrossRef]
  30. Wagle, A.; Seong, S.H.; Jung, H.A.; Choi, J.S. Identifying an isoflavone from the root of Pueraria lobata as a potent tyrosinase inhibitor. Food Chem. 2019, 15, 383–389. [Google Scholar] [CrossRef]
  31. Yang, Y.H.; Dai, S.Y.; Deng, F.H.; Peng, L.H.; Li, C.; Pei, Y.H. Recent advances in medicinal chemistry of oleanolic acid derivatives. Phytochemistry 2022, 203, 113397. [Google Scholar] [CrossRef]
  32. Guo, S.; Duan, J.; Tang, Y.; Qian, Y.; Zhao, J.; Qian, D.; Su, S.; Shang, E. Simultaneous qualitative and quantitative analysis of triterpenic acids, saponins and flavonoids in the leaves of two Ziziphus species by HPLC-PDA-MS/ELSD. J. Pharm. Biomed. Anal. 2011, 56, 264–270. [Google Scholar] [CrossRef]
  33. Laszczyk, M.N. Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy. Planta Med. 2009, 75, 1549–1560. [Google Scholar] [CrossRef]
  34. Salvador, J.A.R.; Leal, A.S.; Valdeira, A.S.; Gonçalves, B.M.F.; Alho, D.P.S.; Figueiredo, S.A.C.; Silvestre, S.M.; Mendes, V.I.S. Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment. Eur. J. Med. Chem. 2017, 142, 95–130. [Google Scholar] [CrossRef] [PubMed]
  35. Yousef, B.A.; Hassan, H.M.; Zhang, L.Y.; Jiang, Z.Z. Anticancer potential and molecular targets of pristimerin: A mini-review. Curr. Cancer Drug Targets 2017, 17, 100–108. [Google Scholar] [CrossRef] [PubMed]
  36. Ahmed, M.; Qin, P.; Ji, M.; An, R.; Guo, H.; Shafi, J. Spinasterol, 22,23-Dihydrospinasterol and Fernenol from Citrullus colocynthis L. with Aphicidal Activity against Cabbage aphid Brevicoryne brassicae L. Molecules 2020, 25, 2184. [Google Scholar] [CrossRef] [PubMed]
  37. Li, X.; Huang, X.; Feng, Y.; Wang, Y.; Guan, J.; Deng, B.; Chen, Q.; Wang, Y.; Chen, Y.; Wang, J.; et al. Cylindrin from Imperata cylindrica inhibits M2 macrophage formation and attenuates renal fibrosis by downregulating the LXR-α/PI3K/AKT pathway. Eur. J. Pharmacol. 2023, 950, 175771. [Google Scholar] [CrossRef] [PubMed]
  38. Li, X.Y.; Lv, J.M.; Cao, Z.Q.; Wang, G.Q.; Lin, F.L.; Chen, G.D.; Qin, S.Y.; Hu, D.; Gao, H.; Yao, X.S. Biosynthetic characterization of the antifungal fernane-type triterpenoid polytolypin for generation of new analogues via combinatorial biosynthesis. Org. Biomol. Chem. 2023, 21, 851–857. [Google Scholar] [CrossRef] [PubMed]
  39. Wang, W.; Liu, P.; Zhang, Y.; Li, J.; Tao, H.; Gu, Q.; Zhu, W. 2-Hydroxydiplopterol, a new cytotoxic pentacyclic triterpenoid from the halotolerant fungus Aspergillus variecolor B-17. Arch. Pharm. Res. 2009, 32, 1211–1214. [Google Scholar] [CrossRef]
  40. Carrero, J.J.; Ortiz, A.G.; Avesani, C.M.; Bakker, S.J.L.; Bellizzi, V.; Chauveau, P.; Clase, C.M.; Cupisti, A.; Cuevas, A.E.; Molina, P.; et al. Plant-based diets to manage the risks and complications of chronic kidney disease. Nat. Rev. Nephrol. 2020, 16, 525–542. [Google Scholar] [CrossRef]
  41. Ghosh, A.; Panda, C.K. Role of pentacyclic triterpenoid acids in the treatment of bladder cancer. Mini-Rev. Med. Chem. 2022, 22, 1331–1340. [Google Scholar] [CrossRef]
  42. Mandal, A.; Ghosh, S.; Bothra, A.K.; Nanda, A.K.; Ghosh, P. Synthesis of friedelan triterpenoid analogs with DNA topoisomerase IIα inhibitory activity and their molecular docking studies. Eur. J. Med. Chem. 2012, 54, 137–143. [Google Scholar] [CrossRef]
  43. Li, W.; Song, Y.; Zhang, P.; Zhu, H.; Chen, L.; Xiao, Y.; Xing, Y. Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway. Tumor. Biol. 2016, 37, 7599–7613. [Google Scholar] [CrossRef]
  44. Shyu, M.H.; Kao, T.C.; Yen, G.C. Oleanolic acid and ursolic acid induce apoptosis in HuH7 human hepatocellular carcinoma cells through a mitochondrial-dependent pathway and downregulation of XIAP. J. Agric. Food. Chem. 2010, 58, 6110–6118. [Google Scholar] [CrossRef]
  45. Mlala, S.; Oyedeji, A.O.; Gondwe, M.; Oyedeji, O.O. Ursolic acid and its derivatives as bioactive agents. Molecules 2019, 24, 2751. [Google Scholar] [CrossRef]
  46. Zuco, V.; Supino, R.; Righetti, S.C.; Cleris, L.; Marchesi, E.; Gambacorti-Passerini, C.; Formelli, F. Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett. 2002, 175, 17–25. [Google Scholar] [CrossRef]
  47. Lin, C.; Wen, X.; Sun, H. Oleanolic acid derivatives for pharmaceutical use: A patent review. Expert Opin. Ther. Pat. 2016, 26, 643–655. [Google Scholar] [CrossRef]
  48. Wu, S.Y.; Wang, W.J.; Dou, J.H.; Gong, L.K. Research progress on the protective effects of licorice-derived 18β-glycyrrhetinic acid against liver injury. Acta Pharmacol. 2021, 42, 18–26. [Google Scholar] [CrossRef]
  49. Xiao, Y.; Xu, J.; Mao, C.; Jin, M.; Wu, Q.; Zou, J.; Gu, Q.; Zhang, Y.; Zhang, Y. 18β-glycyrrhetinic acid ameliorates acute Propionibacterium acnes-induced liver injury through inhibition of macrophage inflammatory protein-1alpha. J. Biol. Chem. 2010, 285, 1128–1137. [Google Scholar] [CrossRef]
  50. Pollier, J.; Goossens, A. Oleanolic acid. Phytochemistry 2012, 77, 10–15. [Google Scholar] [CrossRef]
  51. Aragón, S.M.; Heras, B.; Reus, M.I.S.; Benedi, J. Pharmacological modification of endogenous antioxidant enzymes by ursolic acid on tetrachloride-induced liver damage in rats and primary cultures of rat hepatocytes. Exp. Toxicol. Pathol. 2001, 53, 199–206. [Google Scholar] [CrossRef]
  52. Saravanan, R.; Viswanathan, P.; Pugalendi, K.V. Protective effect of ursolic acid on ethanol-mediated experimental liver damage in rats. Life Sci. 2006, 78, 713–718. [Google Scholar] [CrossRef]
  53. Manna, P.; Sil, P.C. Impaired redox signaling and mitochondrial uncoupling contributes vascular inflammation and cardiac dysfunction in type 1 diabetes: Protective role of arjunolic acid. Biochimie 2012, 94, 786–797. [Google Scholar] [CrossRef]
  54. Zheng, J.; He, J.; Ji, B.; Li, Y.; Zhang, X. Antihyperglycemic effects of platycodon grandiflorum (Jacq.) A. DC. extract on streptozotocin-induced diabetic mice. Plant Foods Hum. Nutr. 2007, 62, 7–11. [Google Scholar] [CrossRef]
  55. Lee, H.; Kang, R.; Kim, Y.S.; Chung, S.I.; Yoon, Y. Platycodin D inhibits adipogenesis of 3T3-L1 cells by modulating kruppel-like factor 2 and peroxisome proliferator-activated receptor γ. Phytother Res. 2010, 24, S161–S167. [Google Scholar] [CrossRef]
  56. Li, S.; Liao, X.; Meng, F.; Wang, Y.; Sun, Z.; Guo, F.; Li, X.; Meng, M.; Li, Y.; Sun, C. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced nonalcoholic fatty liver disease rats. PLoS ONE 2014, 9, e86724. [Google Scholar]
  57. Jung, S.H.; Ha, Y.J.; Shim, E.K.; Choi, S.Y.; Jin, J.L.; Yun-Choi, H.S.; Lee, J.R. Insulin-mimetic and insulin-sensitizing activities of a pentacyclic riterpenoid insulin receptor activator. Biochem. J. 2007, 403, 243–250. [Google Scholar] [CrossRef]
  58. Seo, D.Y.; Lee, S.R.; Heo, J.W.; No, M.H.; Rhee, B.D.; Ko, K.S.; Kwak, H.B.; Han, J. Ursolic acid in health and disease. Korean J. Physiol. Pharmacol. 2018, 22, 235–248. [Google Scholar] [CrossRef]
  59. Ajala-Lawal, R.A.; Aliyu, N.O.; Ajiboye, T.O. Betulinic acid improves insulin sensitivity, hyperglycemia, inflammation and oxidative stress in metabolic syndrome rats via PI3K/Akt pathways. Arch. Physiol. Biochem. 2020, 126, 107–115. [Google Scholar] [CrossRef]
  60. Melo, C.L.; Queiroz, M.G.R.; Filho, A.C.V.A.; Rodrigues, A.M.; Sousa, D.F.; Almeida, J.G.L.; Pessoa, O.D.L.; Silveira, E.R.; Menezes, D.B.; Melo, T.S.; et al. Betulinic acid, a natural pentacyclic triterpenoid, prevents abdominal fat accumulation in mice fed a high-fat diet. J. Agric. Food Chem. 2009, 57, 8776–8781. [Google Scholar] [CrossRef]
  61. Wu, H.F.; Natschke, S.L.M.; Xu, X.D.; Yang, M.H.; Cheng, Y.Y.; Yu, S.S.; Lee, K.H. Recent advances in natural anti-HIV triterpenoids and analogs. Med. Res. Rev. 2020, 40, 2339–2385. [Google Scholar] [CrossRef]
  62. Isah, M.B.; Ibrahim, M.A.; Mohammed, A.; Aliyu, A.B.; Masola, B.; Coetzer, T.H.T. A systematic review of pentacyclic triterpenes and their derivatives as chemotherapeutic agents against tropical parasitic diseases. J. Parasitol. 2016, 143, 1219–1231. [Google Scholar] [CrossRef]
  63. Zhang, Z.; Jiang, M.; Xie, X.; Yang, H.; Wang, X.; Xiao, L.; Wang, N. Oleanolic acid ameliorates high glucose-induced endothelial dysfunction via PPAR delta activation. Sci. Rep. 2017, 7, 40237. [Google Scholar] [CrossRef]
  64. Jo, E.; Choi, M.H.; Kim, H.S.; Park, S.N.; Lim, Y.K.; Kang, C.K.; Kook, J.K. Antimicrobial effects of oleanolic acid, ursolic acid, and Sophoraflavanone G against enterococcus faecalis and propionibacterium acnes. Int. J. Oral Biol. 2014, 39, 75–79. [Google Scholar] [CrossRef]
  65. Liu, R.; Zhang, L.; Xiao, S.; Chen, H.; Han, Y.; Niu, B. Ursolic acid, the main component of blueberry cuticular wax, inhibits Botrytis cinerea growth by damaging cell membrane integrity. Food Chem. 2023, 415, 135753. [Google Scholar] [CrossRef]
  66. Micota, B.; Sadowska, B.; Podsędek, A.; Redzynia, M.; Różalska, B. Leonurus cardiaca L. herb--a derived extract and an ursolic acid as the factors affecting the adhesion capacity of Staphylococcus aureus in the context of infective endocarditis. Acta Biochim. Pol. 2014, 61, 385–388. [Google Scholar] [CrossRef]
  67. Zhi, K.; Wang, J.; Zhao, H.; Yang, X. Self-assembled small molecule natural product gel for drug delivery: A breakthrough in new application of small molecule natural products. Acta Pharm. Sin. B 2020, 10, 913–927. [Google Scholar] [CrossRef]
  68. Yadav, S.; Sharma, A.K.; Kumar, P. Nanoscale self-assembly for therapeutic delivery. Front. Bioeng. Biotechnol. 2020, 8, 127. [Google Scholar] [CrossRef]
  69. Das, D.; Kar, T.; Das, P.K. Gel-nanocomposites: Materials with promising applications. Soft Matter 2012, 8, 2348–2365. [Google Scholar] [CrossRef]
  70. Bag, B.G.; Paul, K. Vesicular and fibrillar gels by self-assembly of nanosized oleanolic acid. Asian J. Org. Chem. 2012, 1, 150–154. [Google Scholar] [CrossRef]
  71. Bag, B.G.; Hasan, S.N.; Ghorai, S.; Panja, S.K. First self-assembly of dihydroxy triterpenoid maslinic acid yielding vesicles. ACS Omega 2019, 4, 7684–7690. [Google Scholar] [CrossRef]
  72. Bag, B.G.; Dash, S.S. First self-assembly study of betulinic acid, a renewable nano-sized, 6-6-6-6-5 pentacyclic monohydroxy triterpenic acid. Nanoscale 2011, 3, 4564–4566. [Google Scholar] [CrossRef] [PubMed]
  73. Zhi, K.; Zhao, H.; Yang, X.; Zhang, H.; Wang, J.; Wang, J.; Regenstein, J.M. Natural product gelators and a general method for obtaining them from organisms. Nanoscale 2018, 10, 3639–3643. [Google Scholar] [CrossRef] [PubMed]
  74. Bag, B.G.; Majumdar, R. Self-assembly of a renewable nano-sized triterpenoid 18β-glycyrrhetinic acid. RSC Adv. 2012, 2, 8623–8626. [Google Scholar] [CrossRef]
  75. Lu, J.; Wu, X.; Liu, L.; Chen, H.; Liang, Y. First organogelation study of ursolic acid, a natural ursane triterpenoid. Chem. Lett. 2016, 45, 860–862. [Google Scholar] [CrossRef]
  76. Bag, B.G.; Das, S.S.; Hasana, S.N.; Barai, A.C. Nanoarchitectures by hierarchical self-assembly of ursolic acid: Entrapment and release of fluorophores including anticancer drug doxorubicin. RSC Adv. 2017, 7, 18136–18143. [Google Scholar] [CrossRef]
  77. Hu, X.; Hou, B.; Xu, Z.; Saeed, M.; Sun, F.; Gao, Z.; Lai, Y.; Zhu, T.; Zhang, F.; Zhang, W.; et al. Supramolecular prodrug nanovectors for active tumor targeting and combination immunotherapy of colorectal cancer. Adv. Sci. 2020, 7, 1903332. [Google Scholar] [CrossRef] [PubMed]
  78. Hoppe, P.P.; Krennrich, G. Bioavailability and potency of natural-source and all-racemic alpha-tocopherol in the human: A dispute. Eur. J. Nutr. 2000, 39, 183–193. [Google Scholar] [CrossRef] [PubMed]
  79. Zhang, J.; Cui, Y.X.; Feng, X.N.; Cheng, M.; Tang, A.N.; Kong, D.M. pH-controlled intracellular in situ reversible assembly of photothermal agent for smart chemo-photothermal synergetic therapy and ATP imaging. ACS Appl. Mater. 2019, 11, 39624–39632. [Google Scholar] [CrossRef]
  80. Liu, S.; Zhang, J.; Fu, R.; Feng, H.; Chu, Y.; Huang, D.; Liu, H.; Li, C.; Ma, C.; El-Aty, A.M.A. Improved stability, epithelial permeability and cellular antioxidant activity of β-carotene via encapsulation by self-assembled α-lactalbumin micelles. Improved stability and aqueous solubility of β-carotene via encapsulation in self-assembled bioactive oleanolic acid nanoparticles. Food Chem. 2022, 373 Pt B, 131498. [Google Scholar]
  81. Wang, J.; Qiao, W.; Zhao, H.; Cheng, J.; Han, Y.; Yang, X. A highly atom-economical bioactive nanocarrier for synergistically enhanced antitumor with reduced liver injury. New J. Chem. 2020, 44, 16741–16751. [Google Scholar] [CrossRef]
  82. Wang, J.; Zhao, H.; Zhi, K.; Yang, X. Exploration of the natural active small-molecule drug-loading process and highly efficient synergistic antitumor efficacy. ACS Appl. Mater. 2020, 12, 6827–6839. [Google Scholar] [CrossRef] [PubMed]
  83. Simard, J.M.; Chen, M.; Tarasov, K.V.; Bhatta, S.; Ivanova, S.; Melnitchenko, L.; Tsymbalyuk, N.; West, G.A.; Gerzanich, V. Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat. Med. 2016, 12, 433–440. [Google Scholar] [CrossRef] [PubMed]
  84. Wang, J.; Qiao, W.; Zhao, H.; Yang, X. Paclitaxel and betulonic acid synergistically enhance antitumor efficacy by forming co-assembled nanoparticles. Biochem. Pharmacol. 2020, 182, 114232. [Google Scholar] [CrossRef] [PubMed]
  85. Cheng, J.; Zhao, H.; Wang, J.; Han, Y. Bioactive natural small molecule-tuned coassembly of photosensitive drugs for highly efficient synergistic and enhanced Type I photochemotherapy. ACS Appl. Mater. 2020, 12, 43488–43500. [Google Scholar] [CrossRef]
  86. Bag, B.; Majumdar, R. Vesicular self-assembly of a natural triterpenoid arjunolic acid in aqueous medium: Study of entrapment properties and in situ generation of gel-gold nanoparticle hybrid material. RSC Adv. 2014, 4, 53327–53334. [Google Scholar] [CrossRef]
  87. Zheng, J.; Fan, R.; Wu, H.; Yao, H.; Yan, Y.; Liu, J.; Ran, L.; Sun, Z.; Yi, L.; Dang, L.; et al. Directed self-assembly of herbal small molecules into sustained release hydrogels for treating neural inflammation. Nat. Commun. 2019, 10, 1604. [Google Scholar] [CrossRef] [PubMed]
  88. Bag, B.G.; Garai, C.; Ghorai, S. Vesicular self-assembly of a natural ursane-type dihydroxy-triterpenoid corosolic acid. RSC Adv. 2019, 9, 15190–15195. [Google Scholar] [CrossRef] [PubMed]
  89. Wang, J.; Qiao, W.; Li, X.; Zhao, H.; Zhang, H.; Dong, A.; Yang, X. A directed co-assembly of herbal small molecules into carrier-free nanodrugs for enhanced synergistic antitumor efficacy. J. Mater. Chem. B 2021, 9, 1040–1048. [Google Scholar] [CrossRef] [PubMed]
  90. Zhang, B.; Jiang, J.; Wu, P.; Zou, J.; Le, J.; Lin, J.; Li, C.; Luo, B.; Zhang, Y.; Huang, R.; et al. A smart dual-drug nanosystem based on co-assembly of plant and food-derived natural products for synergistic HCC immunotherapy. Acta Pharm. Sin. B 2021, 11, 246–257. [Google Scholar] [CrossRef]
  91. Kaps, A.; Gwiazdoń, P.; Chodurek, E. Nanoformulations for delivery of pentacyclic triterpenoids in anticancer therapies. Molecules 2021, 26, 1764–1782. [Google Scholar] [CrossRef]
  92. Garanti, T.; Stasik, A.; Burrow, A.J.; Alhnan, M.A.; Wan, K.W. Anti-glioma activity and the mechanism of cellular uptake of asiatic acid-loaded solid lipid nanoparticles. Int. J. Pharmaceut. 2016, 500, 305–315. [Google Scholar] [CrossRef] [PubMed]
  93. Das, S.; Ghosh, S.; De, A.K.; Bera, T. Oral delivery of ursolic acid-loaded nanostructured lipid carrier coated with chitosan oligosaccharides: Development, characterization, in vitro and in vivo assessment for the therapy of leishmaniasis. Int. J. Biol. Macromol. 2017, 102, 996–1008. [Google Scholar] [CrossRef] [PubMed]
  94. Dai, L.; Cao, X.; Liu, K.; Li, C.; Zhang, G.; Deng, L.; Si, C.; He, J.; Lei, J. 2015. Self-assembled targeted folate-conjugated eight-arm-polyethylene glycol-betulinic acid nanoparticles for co-delivery of anticancer drugs. J. Mater. Chem. B 2015, 3, 3754–3766. [Google Scholar] [CrossRef] [PubMed]
  95. Saharkhiz, S.; Zarepour, A.; Zarrabi, A. A new theranostic pH-responsive niosome formulation for doxorubicin delivery and bio-imaging against breast cancer. Int. J. Pharm. 2023, 637, 122845. [Google Scholar] [CrossRef] [PubMed]
  96. Zhu, Y.; Ling, J.; Xu, X.; Ouyang, X.K.; Wang, N. Redox and pH dual sensitive carboxymethyl chitosan functionalized polydopamine nanoparticles loaded with doxorubicin for tumor chemo-photothermal therapy. Int. J. Biol. Macromol. 2023, 240, 124488. [Google Scholar] [CrossRef] [PubMed]
  97. Guo, M.; Lu, X.; Wang, Y.; Brodelius, P.E. Comparison of the interaction between lactoferrin and isomeric drugs. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2017, 173, 593–607. [Google Scholar] [CrossRef]
  98. Wu, Z.C.; Liu, X.Y.; Liu, J.Y.; Piao, J.S.; Piao, M.G. Preparation of betulinic acid galactosylated chitosan nanoparticles and their effect on liver fibrosis. Int. J. Nanomed. 2022, 17, 4195–4210. [Google Scholar] [CrossRef]
Foods 13 02226 g001
Figure 1. Overview of food-source pentacyclic triterpenoids. Four vital types are summarized, including oleanane-type (e.g., oleanolic acid, glycyrrhetinic acid, arjunolic acid, maslinic acid), ursane-type (e.g., ursolic acid, corosolic acid, asiatic acid), lupane-type (e.g., betulinic acid, betulonic acid, lupeol) and friedelane-type (e.g., friedelin, friedelanol).
Figure 1. Overview of food-source pentacyclic triterpenoids. Four vital types are summarized, including oleanane-type (e.g., oleanolic acid, glycyrrhetinic acid, arjunolic acid, maslinic acid), ursane-type (e.g., ursolic acid, corosolic acid, asiatic acid), lupane-type (e.g., betulinic acid, betulonic acid, lupeol) and friedelane-type (e.g., friedelin, friedelanol).
Foods 13 02226 g001
Foods 13 02226 g002
Figure 2. The main biological activities of pentacyclic triterpenoids include anti-tumor, hepatoprotective, glucose regulating and others.
Figure 2. The main biological activities of pentacyclic triterpenoids include anti-tumor, hepatoprotective, glucose regulating and others.
Foods 13 02226 g002
Foods 13 02226 g003
Figure 3. Overview of several research perspectives of pentacyclic triterpenoids in food science [21,76].
Figure 3. Overview of several research perspectives of pentacyclic triterpenoids in food science [21,76].
Foods 13 02226 g003
Table 1. Nanoparticle carriers for transporting bioactive components.
Table 1. Nanoparticle carriers for transporting bioactive components.
CarrierLoaded CompoundsLC&EEInteraction ForcesPhysicochemical PropertiesFunctional Activities References
Oleanolic acidCar 32.6 ± 0.0%;
80.7 ± 0.1%.		Hydrogen bonding; hydrophobic interactions.Increased aqueous solubility and protection against UV radiation ionic strength, and heat. Delayed release in simulated gastric conditions and controlled release in simulated intestinal conditions.Enhanced hepatoprotective and antioxidant effects.[80]
Oleanolic acidPTX17.1 ± 0.0%; 62.6 ± 0.0%.Hydrophobic interactions;
hydrogen bonding.		Increased stability, slowed and sustained release under acidic conditions. Tumor inhibition rate was 76.54 ± 0.66%, about 18% higher than that of PTX group. Reduced liver injury.[81]
Ursolic acidPTX23.12 ± 1.07%; 94.41 ± 4.28%,Hydrophobic interactions;
hydrogen bonding.		More stable in PBS for at least 15 days, in serum for 24 h and also under acidic conditions. Controlled release after entering the cells.Prolonged plasma half-life. Tumor inhibition rate was 90.2%, 3.3 times higher than that of PTX group. Reduced liver injury.[82]
Ursolic acidRho B/CF/DOXHydrogen bonding; Van der Waals interactions.Controlled release of Rho B at physiological conditions. Slow release of DOX at physiological conditions and pH 6.6._[77]
Betulinic acidGlyburide__Increase the delivery to the brain. Controllably released over three days.Synergetic effects for ischemic stroke by antioxidant and anti-edema.[23]
Betulonic acidPTX_Hydrogen bonding; hydrophobic interaction. Improved water solubility. More stable under acidic conditions. Synergistic anti-tumor efficacy and minimize the side effects.[83]
Betulonic acidCe6_π-π stacking; hydrophobic interactions.Excellent water dispersity. Keep stable in water, cell cultural medium and PBS buffer (pH 7.4). Have better photostability.prolonged blood circulation. Synergistic anticancer efficacy.[84]
Arjunolic acidRho B/CF/DOXHydrogen bondingSlow release of PTX at physiological pH (7.2). _[85,86]
Corosolic acidRho B/CF/DOXHydrogen bonding; Van der Waals interactions.Triton X-100-triggered release of Rho-B._[87,88]
Maslinic acidRho B/ CF/ DOX Hydrogen bonding; lipophilic interactions.Triton X-100-triggered release of DOX._[71]
Car; carotene; PTX: paclitaxel; Rho B: Rhodamine B; CF: 5,6-carboxfluorescein; DOX: doxorubicin; Ce6: chlorin e6.
Table 2. Nanoparticle carriers for transporting bioactive components.
Table 2. Nanoparticle carriers for transporting bioactive components.
CarrierLoaded CompoundsLC&EEInteraction forcesPhysicochemical PropertiesFunctional Activities References
Oleanolic acid -glycyrrhetinic acidPTX15.1 ± 0.4%, 98.8 ± 1.0%Hydrogen bonding; hydrophobic interactions.Stable under acidic conditions. Have good dispersion and chemical stability. Tumor inhibition rate was 82.6%, 23.7% higher than the PTX group. Reduced liver damage and nanotoxicity.[22]
Glycyrrhetinic acid—oleanolic acid-Hydrogen bonding; hydrophobic interactions.-Tumor inhibition rate was
Enhanced from 50.5% to 69.5%. Reliable biosafety.		[89]
Glycyrrhetinic acid-Liquidambaric acid-Hydrogen bonding; hydrophobic interactions.-Tumor inhibition rate was
Enhanced from 37.3% to 82.9%. Reliable biosafety.		[89]
Ursolic acid -EGCG-aptamer73.6%Hydrophobic
interactions; hydrogen bonding. 		pH-responsive, released rapidly in acid conditions.Synergistic anticancer effect. Enhanced tumor immune infiltration.[90]
EGCG: epigallocatechin gallate.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Teng, W.; Zhou, Z.; Cao, J.; Guo, Q. Recent Advances of Natural Pentacyclic Triterpenoids as Bioactive Delivery System for Synergetic Biological Applications. Foods 2024, 13, 2226. https://doi.org/10.3390/foods13142226

AMA Style

Teng W, Zhou Z, Cao J, Guo Q. Recent Advances of Natural Pentacyclic Triterpenoids as Bioactive Delivery System for Synergetic Biological Applications. Foods. 2024; 13(14):2226. https://doi.org/10.3390/foods13142226

Chicago/Turabian Style

Teng, Wendi, Zixiao Zhou, Jinxuan Cao, and Qing Guo. 2024. "Recent Advances of Natural Pentacyclic Triterpenoids as Bioactive Delivery System for Synergetic Biological Applications" Foods 13, no. 14: 2226. https://doi.org/10.3390/foods13142226

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop